# A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China

> **NCT07040306** · — · RECRUITING · sponsor: **First Hospital of China Medical University** · enrollment: 1000 (estimated)

## Conditions studied

- Graves´ Disease

## Interventions

- **DRUG:** Methimazole(MMI)

## Key facts

- **NCT ID:** NCT07040306
- **Lead sponsor:** First Hospital of China Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2012-11-14
- **Primary completion:** 2030-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040306, "A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07040306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*